Table 1.
Mouse Model | Oncogenic Expression | Human Breast Cancer Subtype | Ref. |
---|---|---|---|
MMTV-Wnt1 | Wnt1 overexpression | Basal-like | [75] |
WAP-Tag | SV40 large T antigen | Basal-Like | [74] |
WAP-Int3 | Notch 4 overexpression | Luminal-Like | [78] |
MMTV-Hras | Hras overexpression | Luminal A | [72] |
MMTV-PyMT | Activation of Src, PI3K, and Shc | Luminal B | [77] |
MMTV-Neu | Inactivated rat ErbB2 overexpression in MECs | HER2-enriched | [76] |
WAP-Cre/Etv6 | Etv6-Ntrk3 fusion gene overexpression | HER2-enriched | [82] |
Brg1+/− | Brg1 heterozygous | HER2-enriched | [79] |
p18−/− | Cdkn2c homozygous null | HER2-enriched | [80] |
Rb−/− | Rb homozygous null | HER2-enriched | [80] |
MMTV-Fgf3 | Fgf3 overexpression | HER2-enriched | [83] |
MMTV-Lpa |
Lpa1, Lpa2, or Lpa3 overexpression |
Mesenchymal-like | [69] |
p53+/− irradiated | Trp53 heterozygous, irradiated | Mesenchymal-like | [71] |
DMBA-induced | Random DMBA induction | Basal-like Mesenchymal-like |
[68] |
C3(1)-Tag | pRb, p107, p130, p53, p300 inactivation and others in MECs | Basal-like Mesenchymal-like |
[44] |
WAP-Myc | Myc overexpression in LCs | Basal-like Luminal B |
[73] |
MMTV-Myc | Myc overexpression | Basal-like Luminal B |
[72] |
MMTV-Cre/Brca1Co/Co/p53+/− | Brca1 truncation in MECs, Tp53 heterozygous null | Basal-like Mesenchymal-like |
[67] |
MMTV-Aib1 | Aib1 overexpression | Basal-Like Luminal B HER2-enriched |
[69] |
WAP-T121 | pRb, p107 and p130 inactivation in LCs | HER2-enriched Mesenchymal-like |
[70] |